In the 1950s, when the first chemotherapy drugs began to hit the market, Leukemia was reportedly 100% fatal. Over the last two decades however, the long-term survival rate of blood cancers has significantly increased thanks to breakthroughs in immunotherapy, genomics, and personalized medicine.
The Leukemia & Lymphoma Society (LLS) is the world’s largest voluntary health organization dedicated to funding blood cancer research. Since 1949, LLS has invested nearly $1.7 billion in research and provides hope, education, and support to patients and their families.
In support of LLS, its mission to cure cancer, and its goal to improve the quality of life for patients and their families, our company was proud to raise and donate a total of $11,868.
This year, Pond stepped forward in commitment to compassion by uplifting the millions of men, women, and children who have been affected by blood cancer. In support of LLS, its mission to cure cancer, and its goal to improve the quality of life for patients and their families, our company was proud to raise and donate a total of $11,868.